COMP <GO>
ONMD vs BIAF // ENTERPRISE SCALE & MARKET CAP
OneMedNet Corp (Class A) (NASDAQ) VS. bioAffinity Technologies Inc. (NASDAQ) • 15-METRIC TALLY: ONMD 3
— BIAF 0
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ONMD
LAST: $4.37 (-2.02%) • MKT CAP: $26.3M
market-cap
$26.3M
LAST: $3.03 (-3.50%) • MKT CAP: $3.9M
market-cap
$3.9M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ONMD VS. BIAF)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ONMD | BIAF | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | -30.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 111.40% | -34.20% | +145.60 | ONMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 2/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.7 | 34.0 | +3.73 | ONMD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $26.3M | $3.9M | $22.4M | ONMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ONMD REV | BIAF REV | ONMD GROSS % | BIAF GROSS % | ONMD FCF | BIAF FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.4M | $6.2M | -37.0% | — | -$7.5M | -$9.4M |
| FY 2024 | $643.0K | $9.4M | -43.7% | — | -$7.0M | -$7.3M |
| FY 2023 | $1.0M | $2.5M | — | — | -$4.8M | -$6.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ONMD // BETA —
BIAF // BETA —